south nsg6440 week 10 discussion (dq1+dq2)
Week 10 – Assignment 1 Discussion
Assignment 1: Evidence-Based Clinical Intervention
By Friday, December 8, 2017, submit your Evidence-Based Clinical Intervention to the Discussion Area.
Your Evidence-Based Clinical Intervention should be submitted in a Microsoft Word document following APA style and should include the following:
ORDER A CUSTOM-WRITTEN PAPER NOW
- The medical problem/diagnosis/disease.
- Typical presenting signs and symptoms including:
- Onset, Characteristics, Location, Radiation, Timing, Setting, Aggravating factors, Alleviating factors, Associated symptoms, Course since onset, Usual age group affected
- Concomitant disease states associated with the diagnosis
- The pathophysiology of the problem.
- Three differential diagnoses and the usual presenting signs and symptoms in priority sequence with rationales.
- Reference to at least two current journal articles that show evidence-based practice as how to best treat this disorder related to the primary differential.
- The expected outcomes of the intervention.
- Algorithms if available.
A typical clinical note in SOAP format.
Respond to at least two of your classmates’ Evidence-Based Clinical Interventions using the lessons and vocabulary found in the reading. Support your answers with examples and research. Your responses should clarify your understanding of the topic. They should be your own, original, and free from plagiarism. Follow the APA format for writing style, spelling and grammar, and citation of sources.
Week 10 -Assignment 2 Discussion
Assignment 2: Reflection
By Saturday, December 9, 2017, reflect on the course and what you have learned over the last ten weeks. Write up a brief summary of how you meet each course objective. Include examples from both the course and practicum experiences.
Post your response to the Discussion Area by Saturday, December 9, 2017. Include references to support your work. Respond to at least two of your peers providing substantial feedback supported with references.